Charles River Associates publishes CRA Insights, a newsletter highlighting recent thinking and announcements from members of our Life Sciences Practice.
ESMO 2025 Review: Bring me the horizon
From these sessions, CRA’s Aaron Everitt highlighted that while there are still relevant data releases and findings on existing immune checkpoint inhibitors,...